Vol 2025, No 10 (2025)

Table of Contents

Research & Development

Takeda Signs US$11.4 B Oncology Partnership with Innovent Biologics Abstract pdf html
Lucy Haggerty

Licensing

Novo Nordisk Expands Rare Disease Pipeline with US$2.4 B Omeros Partnership Abstract pdf html
Hitesh Udar

Mergers & Acquisitions

Pfizer Expands Obesity Portfolio with US$4.9 B Acquisition of Metsera Abstract pdf html
Shikha Kashyap
Roche to Acquire 89bio and its FGF21 Analogue Lead Asset for US$3.5 B Abstract pdf html
Naini Anand
BioCryst to Acquire Astria Therapeutics for up to US$700 M Abstract pdf html
Ayush Saxena
Novo Nordisk Strengthens Metabolic Pipeline with US$5.2 B Acquisition of Akero Therapeutics Abstract pdf html
Swati Sharan
Genmab Strengthens Oncology Pipeline with US$8 B Acquisition of Merus Abstract pdf html
Naini Anand
Bristol Myers Squibb to Acquire Orbital Therapeutics and its RNA Platform for US$1.5 B Abstract pdf html
Swati Sharan


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.